fluorouracil has been researched along with silybin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, HR; Chen, PN; Chu, SC; Hsieh, YS; Hung, TW; Lian, JD; Sun, YS; Wu, SW; Yang, SF | 1 |
| Chan, KT; Chan, KW; Cheung, AL; Guan, XY; Law, S; Lee, NP; Li, B; Li, J; Qin, YR; Tsao, SW; Xu, WW | 1 |
| Mirza, S; Patel, S; Pathak, C; Rawal, R; Shah, K; Vaidya, F; Waghela, B | 1 |
| Ayazoglu Demir, E; Demir, S; Kucuk, H; Mentese, A; Turkmen Alemdar, N | 1 |
5 other study(ies) available for fluorouracil and silybin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Renal Cell; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Fluorouracil; HEK293 Cells; Humans; Kidney Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Paclitaxel; Silybin; Silymarin; Urokinase-Type Plasminogen Activator; Xenograft Model Antitumor Assays | 2011 |
Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Signal Transduction; Silybin; Silymarin; Xenograft Model Antitumor Assays | 2016 |
Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Colonic Neoplasms; Fluorouracil; G1 Phase; HCT116 Cells; Humans; Hyaluronan Receptors; MAP Kinase Signaling System; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Resting Phase, Cell Cycle; Silybin | 2018 |
The therapeutic effect of silibinin against 5-fluorouracil-induced ovarian toxicity in rats.
Topics: Animals; Antioxidants; Caspase 3; Fluorouracil; Oxidants; Oxidative Stress; Rats; Silybin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |